Valion Bio (TIVC) Equity Ratio (2021 - 2025)
Valion Bio has reported Equity Ratio over the past 5 years, most recently at 0.53 for Q4 2025.
- For Q4 2025, Equity Ratio fell 41.15% year-over-year to 0.53; the TTM value through Dec 2025 reached 0.53, down 41.15%, while the annual FY2025 figure was 0.53, 41.15% down from the prior year.
- Equity Ratio for Q4 2025 was 0.53 at Valion Bio, down from 0.55 in the prior quarter.
- Over five years, Equity Ratio peaked at 0.9 in Q4 2024 and troughed at 0.53 in Q4 2025.
- A 5-year average of 0.74 and a median of 0.73 in 2025 define the central range for Equity Ratio.
- Biggest five-year swings in Equity Ratio: soared 30.09% in 2024 and later tumbled 41.15% in 2025.
- Year by year, Equity Ratio stood at 0.88 in 2021, then crashed by 30.0% to 0.62 in 2022, then rose by 12.35% to 0.69 in 2023, then skyrocketed by 30.09% to 0.9 in 2024, then tumbled by 41.15% to 0.53 in 2025.
- Business Quant data shows Equity Ratio for TIVC at 0.53 in Q4 2025, 0.55 in Q3 2025, and 0.73 in Q2 2025.